PHB2 and metabolic dysfunction-associated steatotic liver disease: Additionally, emerging regulators, including FUN14 domain-containing protein 1, prohibitin 2, ceramide signaling and non-coding RNAs, which fine-tune mitophagy in NAFLD are highlighted.